Recently, Mr.
Zhao was admitted to Changsha Traditional Chinese Medicine Hospital (Changsha No.
8
Anzhou District, Mianyang City, Sichuan Province: Taking strong and effective measures to ensure the safety of special foods
Time of Update: 2021-07-21
They also carried out special food safety inspections, focusing on checking whether special counters were set up, whether the certificate and ticket requests were complete, whether the permitted business scope was standardized, whether there were false propaganda, advertisements, etc.
Frequent dinners to eat acute pancreatitis, excessive drinking, food oil
Time of Update: 2021-07-20
The Chinese New Year is also a period of high incidence of gastrointestinal diseases. The news of "acute pancreatitis induced by frequent meals" has attracted the attention of many
The EU approves the first single-dose COVID-19 vaccine
Time of Update: 2021-07-19
On March 12, the European Medicines Agency announced on the 11th that it had evaluated the results of a new crown vaccine developed by Johnson & Johnson's Janssen Pharmaceutical Co.
The first patient in the Phase III clinical trial of Hebo Medicine Tenacept was successfully enrolled in the group
Time of Update: 2021-07-19
Tenacept (HBM9036) is a global innovative tumor necrosis factor receptor blocker for adult patients with moderate to severe dry eye .
500 million injections
Time of Update: 2021-07-19
Under review and approval (in the Center for Drug Evaluation); Dexmedetomidine Hydrochloride and Sodium Chloride Injection has Yangzijiang Pharmaceutical Group, Hunan Kelun Pharmaceutical, and Chengdu Beite Pharmaceutical to submit marketing applications for generic 3 types.
In 2020, Sichuan Province's industrial manufacturing green system will be initially established
Time of Update: 2021-07-19
pilot demonstration projects for the creation of green parks. Promote the integrated solution of the park's integrated energy and resources, realize the cascade utilization of energy in the park, the recycling of water resources
Genting Xinyao Announces China National Medical Products Administration Accepts Xerava(TM) Drug Marketing Authorization Application for the Treatment of Adults with Complex Intra-abdominal Infections
Time of Update: 2021-07-15
XeravaTM (eravacycline, eravacycline) is used for the treatment of adult complicated intra-abdominal infection (cIAI) in China for the drug marketing authorization application .
Sanofi CEO Han Paulo: The epidemic makes us firmer in our mission
Time of Update: 2021-07-15
Paul Han believes: “This epidemic shows that it is very important to establish strong pharmaceutical and vaccine production bases around the world to ensure that patients get the necessary medicines .
The Yangtze River Delta Drug Purchasing Alliance is really here
Time of Update: 2021-07-15
But the difference is that last year, the relevant news was that Shanghai organized some regional procurements, but according to this notification document, the Anhui Provincial Medical Insurance Bureau took the lead in this work .
Since April, Xi'an prohibits the sale of high volatile toxic and harmful thinners
Time of Update: 2021-07-15
. Study its formation mechanism and propose a set of practical control countermeasures. Evaluate the effectiveness of comprehensive rectification of volatile organic compounds in key industries, and prepare
Jianshi Medical and Shockwave Medical establish a joint venture company to introduce "intravascular shock wave" calcification treatment technology
Time of Update: 2021-07-14
With the acquisition of medicated chocolate balloon technology and the establishment of a joint venture with Shockwave, HealthScience already has two innovative products for the treatment of peripheral and coronary artery diseases .
National price linkage
Time of Update: 2021-07-14
Medical Network News on March 24th, the government issued a document, the results of the price linkage of high-value consumables in Shandong Province were announced. A few days
Chuangsheng Group announced the appointment of Dr. Xichen Zhang as Senior Vice President of Production and Dr. Jie Yu as Senior Vice President of Pharmacokinetics and Translational Medicine
Time of Update: 2021-07-14
Before joining Chuangsheng Group, he served as Amgen's product quality director, leading the quality work of multiple new drug development projects in different clinical development stages including Sensipar/Mimpara, Parsabiv, AMG223, AMG282, AMG420, AMG479, AMG592 and AMG510 .
Shengli mud logging uses "X-ray" technology to check the quasi horizon
Time of Update: 2021-07-14
technology is similar to the “X-ray” perspective used in medicine. It can accurately analyze and determine the types and contents of more than 30 elements in the rock, and present the interpretation results in the form of a combination of color
Nature Pharmaceutical Announces Pricing and Listing of Initial Public Offering
Time of Update: 2021-07-14
Without deducting underwriter discounts and related issuance expenses, the company's public offering is expected to raise a total of US$25 million .
CStone Pharmaceuticals Announces Approval of China's First Selective RET Inhibitor, Phuket Hua
Time of Update: 2021-07-14
inhibitor, and CStone Pharmaceuticals also ushered in its first commercialized product . > Dr. Jiang Ningjun, Chairman and Chief Executive Officer of CStone
